PMID- 15867334 OWN - NLM STAT- MEDLINE DCOM- 20050706 LR - 20181201 IS - 0022-3166 (Print) IS - 0022-3166 (Linking) VI - 135 IP - 5 DP - 2005 May TI - Plasma ghrelin concentrations are lower in binge-eating disorder. PG - 1326-30 AB - Binge-eating disorder (BED), characterized by binge meals without purging afterward, is found in about 30% of obese individuals seeking treatment. The study objective was to ascertain abnormalities in hormones influencing appetite in BED, especially ghrelin, an appetite-stimulating peptide, which was expected to be elevated. Measurements were made of plasma insulin, leptin, glucagon, cholecystokinin, and ghrelin, as well as glucose following an overnight 12-h fast, prior to and after ingestion (from 0 to 5 min) of a nutritionally complete liquid meal (1254 kJ) at 0830 h, at -15, 0, 5, 15, 30, 60, 90, and 120 min. Appetite ratings including hunger and fullness were also obtained. An acetaminophen tracer was used to assess gastric emptying rate. Three groups of comparably obese women (BMI = 35.9 +/- 5.5; % body fat = 44.9 +/- 4.7) participated: 12 nonbinge eating normals (NB), 14 subthreshold BED, and 11 BED. The BED subjects, compared to NB subjects, had lower baseline ghrelin concentrations prior to the meal, a lower area under the curve (AUC), with lower levels at 5, 15, 30, 90, and 120 min, and a smaller decline in ghrelin postmeal (all P < 0.03). The other blood values did not differ among groups, and neither did gastric emptying rate nor ratings of fullness. The BED subjects were then randomly assigned to treatment with cognitive-behavior therapy and diet (n = 5) or to a wait-list control (n = 4). Baseline ghrelin (P = 0.01) and AUC increased (P = 0.02), across both conditions, in which most subjects (7 of 9) stopped binge eating. The lower fasting and postmeal plasma ghrelin levels in BED are consistent with lower ghrelin levels in obese compared to lean individuals and suggests downregulation by binge eating. FAU - Geliebter, Allan AU - Geliebter A AD - Department of Medicine, New York Obesity Research Center, St. Luke's Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY, USA. ag58@columbia.edu FAU - Gluck, Marci E AU - Gluck ME FAU - Hashim, Sami A AU - Hashim SA LA - eng GR - DK54318/DK/NIDDK NIH HHS/United States GR - R03 DK068603-02/DK/NIDDK NIH HHS/United States GR - DK 26687/DK/NIDDK NIH HHS/United States GR - M01 RR0064529/RR/NCRR NIH HHS/United States GR - R03 DK068603/DK/NIDDK NIH HHS/United States GR - R03 DK068603-01A2/DK/NIDDK NIH HHS/United States PT - Clinical Trial PT - Comparative Study PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, N.I.H., Extramural PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Nutr JT - The Journal of nutrition JID - 0404243 RN - 0 (Blood Glucose) RN - 0 (Ghrelin) RN - 0 (Leptin) RN - 0 (Peptide Hormones) RN - 9011-97-6 (Cholecystokinin) SB - IM MH - Adult MH - Appetite/physiology MH - Area Under Curve MH - Blood Glucose/metabolism MH - Body Mass Index MH - Bulimia/*blood/therapy MH - Cholecystokinin/blood MH - Cognitive Behavioral Therapy MH - Diet MH - Female MH - Ghrelin MH - Humans MH - Leptin/blood MH - Obesity/blood MH - Peptide Hormones/*blood MH - Postprandial Period MH - Premenopause MH - Reference Values EDAT- 2005/05/04 09:00 MHDA- 2005/07/07 09:00 CRDT- 2005/05/04 09:00 PHST- 2005/05/04 09:00 [pubmed] PHST- 2005/07/07 09:00 [medline] PHST- 2005/05/04 09:00 [entrez] AID - 135/5/1326 [pii] AID - 10.1093/jn/135.5.1326 [doi] PST - ppublish SO - J Nutr. 2005 May;135(5):1326-30. doi: 10.1093/jn/135.5.1326.